Sonire Therapeutics reported raising $18 Million in an initial SEC Form D filing, from an offering of $13.5 Million
Round Type
Series A
Investors
Description
Sonire Therapeutics announced $18M in Series A financing to advance its unique non-invasive cancer treatment. The funding will support the world's first randomized HIFU trial for pancreatic cancer and U.S. regulatory progress. Led by Santé Ventures, this round includes notable participation from several Japanese investors
Quick answer
Sonire Therapeutics raised $18 Million in a Series A round, dated March 31, 2026. Investors: Nomura Sparx Investment (Japan Growth Capital Investment Corporation), SBI Investment, Nedo, Fast Track Initiative and Santé Ventures.
- How much did Sonire Therapeutics raise?
- Sonire Therapeutics raised $18 Million in a Series A round on March 31, 2026.
- Who invested in Sonire Therapeutics?
- Nomura Sparx Investment (Japan Growth Capital Investment Corporation), SBI Investment, Nedo, Fast Track Initiative and Santé Ventures are named as investors in this round.
- What does Sonire Therapeutics do?
- Sonire Therapeutics Inc. is a clinical-stage medical device company pioneering sonic technology to treat cancer in a way that is not only more effective but less invasive for patients.
- Where is Sonire Therapeutics based and how big is it?
- Fundz records about 6 employees.
- Who are the decision-makers at Sonire Therapeutics?
- Fundz holds 2 contacts at Sonire Therapeutics, including the President & CEO, Founder. Names and contact details are shown to Fundz members.
Source: Fundz verified event record.
Who else raised in Medical and Medical Device around the same time
Companies in the same sectors as Sonire Therapeutics that raised within 45 days of this round, from Fundz verified event records.
- Combat Medical raised $3.5M (Series A) on March 12, 2026.
- Butterfly Medical Ltd raised $21M (Series C) on May 14, 2026.
- Sedivention raised $3.4M (Seed) on May 7, 2026.
- Citius Oncology raised $37M on May 6, 2026.
- Nervonik raised $53M (Series B) on April 27, 2026.
- TransCode Therapeutics raised $20M (Funding Round) on April 7, 2026.
Who to call at Sonire Therapeutics, and when
A new round usually means Sonire Therapeutics is about to hire and buy. The teams that reach out first get the meeting.
- An alert the day Sonire Therapeutics raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Sonire Therapeutics, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Sonire Therapeutics. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Sonire Therapeutics raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Funding Insights
What this usually meansSonire Therapeutics raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.